Asklepios Kliniken GmbH made voluntary public takeover offer to acquire an additional 58.93% stake in RHÖN-KLINIKUM Aktiengesellschaft (XTRA:RHK) from HCM SE, B. Braun Melsungen AG, Landeskrankenhilfe V.V.A.G, Asset Management Arm and others for approximately €710 million on February 28, 2020. Asklepios Kliniken Verwaltungsgesellschaft mbH will acquire shares at a price of €18 per share. Eugen Münch will continue to play a central role at RHÖN. In related transaction, Asklepios Kliniken Verwaltungsgesellschaft mbH will acquire 6.94% and 5.4% stake from Eugen Münch and Ingeborg Münch respectively. Asklepios Kliniken entered into a syndicated facility agreement with BNP Paribas Fortis to finance the transaction. Asklepios Kliniken can draw up to €875 million under this facility. RHÖN is to remain an independent company following completion of the transaction. The consummation of the offer is subject to merger control clearance by the German Federal Cartel Office (Bundeskartellamt). The transaction was resolved on April 22, 2020. As of April 22, 2020, the Board of RHÖN-KLINIKUM Aktiengesellschaft recommended its shareholders to accept the offer. As of May 26, 2020, German Federal Cartel Office approved the transaction. The transaction is expected to be completed in the second quarter of 2020. As reported on April 8, 2020, acceptance period runs from April 8, 2020 to May 6, 2020. As reported on June 18, 2020, additional acceptance period runs from June 23, 2020 to July 6, 2020. Jefferies International provided the fairness opinion that offer price is adequate. Staffan Illert, Dirk Horcher, Neil Weiand, Carsten Grave, Ulli Janssen, Urs Lewens, Ingo Klauß, Christopher Kuhn, Moritz Hechenrieder, Roman Seifert, Markus Althoff, Jan Liersch and Karin Labisch of Linklaters Oppenhoff & Rädler acted as legal advisor to Asklepios Kliniken GmbH. Christian Zschocke, Ulrich Korth, Michael Masling and Torsten Schwarze of Morgan Lewis & Bockius acted as legal advisor to Eugen Münch and his wife. Henning Schneider and Andreas Lanner of Latham & Watkins Schön Nolte acted as legal advisor to RHÖN-KLINIKUM. Seufert Rechtsanwälte acted as legal advisor to supervisory Board of RHÖN-KLINIKUM. Esther Jansen of Shearman & Sterling acted as legal advisor to BNP Paribas. Hartmut Paulus and Stefan Spruck of BDO AG Wirtschaftsprüfungsgesellschaft, Investment Banking Arm acted as financial advisor to Asklepios Kliniken GmbH. Morgan Stanley Europe SE acted as financial advisor and fairness opinion provider for the management Board of RHÖN-KLINIKUM. Jefferies International Limited acted as fairness opinion provider for RJ-iön-KUmkum. BNP Paribas SA acted as financial advisor to Asklepios Kliniken GmbH & Co. KGaA. Dominik Heß, Christian Vogel and Andreas Dietzel of Clifford Chance, Düsseldorf acted as legal advisor to RHÖN-KLINIKUM Aktiengesellschaft in the transaction.